Anteris Technologies Global (AVR) Cash from Investing Activities (2024 - 2026)
Anteris Technologies Global (AVR) posted quarterly Cash from Investing Activities of -$182000.0 for Q1 2026, down 116.4% year-over-year from $1.1 million in Q1 2025, and up 54.16% quarter-over-quarter from -$397000.0 in Q4 2025.
Anteris Technologies Global (AVR) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported Cash from Investing Activities for 3 consecutive years, with -$182000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 116.4% year-over-year to -$182000.0; the TTM figure through Mar 2026 stood at -$1.9 million (down 316.78% YoY), while the FY2025 annual figure was -$596000.0, up 73.86% from the prior year.
- Cash from Investing Activities grew to -$182000.0 in Q1 2026 per AVR's latest filing, from -$397000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $1.1 million in Q1 2025 and bottomed at -$772000.0 in Q3 2025.
- Historically, Cash from Investing Activities has averaged -$339777.8 across 3 years, with a median of -$537000.0 in 2025.
- Annual changes were most pronounced in 2025 — Cash from Investing Activities surged 254.81% — and 2026, when it sank 116.4%.
- Anteris Technologies Global's Cash from Investing Activities stood at -$364000.0 in 2024, then decreased by 9.07% to -$397000.0 in 2025, then jumped by 54.16% to -$182000.0 in 2026.
- Business Quant data shows AVR's Cash from Investing Activities at -$182000.0 in Q1 2026, -$397000.0 in Q4 2025, and -$772000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Anteris Technologies Global | 875.09 Mn | 875.09 Mn | 776,000.00 | -648,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -648,000.00 |
| Jun 30, 2026 | -648,000.00 |
| Mar 31, 2026 | -182,000.00 |
| Mar 31, 2026 | -182,000.00 |
| Dec 31, 2025 | -397,000.00 |
| Dec 31, 2025 | -397,000.00 |
| Sep 30, 2025 | -772,000.00 |
| Sep 30, 2025 | -772,000.00 |
| Jun 30, 2025 | -537,000.00 |
| Jun 30, 2025 | -537,000.00 |
| Mar 31, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | -364,000.00 |
| Dec 31, 2024 | -364,000.00 |
| Sep 30, 2024 | -553,000.00 |
| Sep 30, 2024 | -553,000.00 |
| Jun 30, 2024 | -646,000.00 |
| Jun 30, 2024 | -646,000.00 |
| Mar 31, 2024 | -717,000.00 |
| Mar 31, 2024 | -717,000.00 |